Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03553095 · ClinicalTrials.gov registry record · NA

Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis

A NA study of Depression and Chronic Periodontitis, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
92
Enrollment target
1
Study location

NCT03553095 is a NA study of Depression and Chronic Periodontitis that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 92 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03553095, a NA study of Depression and Chronic Periodontitis, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate whether use of antidepressants can reduce gingival inflammation in patients with periodontal (gum) disease.

Interventions

  • PROCEDURE Periodontal Surgery

Study Locations (1)

Alabama

  • Unversity of Alabama at Birmingham, School of Dentistry - Birmingham

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2018-07-12
Est. Completion 2026-12-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03553095

The ClinicalTrials.gov registry entry for NCT03553095 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (88% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Periodontal Surgery is the first listed.

NCT03553095 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT03553095 about?

NCT03553095 is a clinical study titled "Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis". This study will evaluate whether use of antidepressants can reduce gingival inflammation in patients with periodontal (gum) disease.

What is the current status of trial NCT03553095?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2018-07-12. Estimated completion is 2026-12-30.

What conditions does trial NCT03553095 study?

This clinical trial studies the following conditions: Depression, Chronic Periodontitis.

What interventions are being tested in trial NCT03553095?

The interventions under investigation include: Periodontal Surgery (PROCEDURE).

Who is sponsoring clinical trial NCT03553095?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03553095 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.